NASDAQ:PAVM

PAVmed (PAVM) Stock Price, News & Analysis

PAVmed logo
$1.51 -0.24 (-13.71%)
Closing price 03:57 PM Eastern
Extended Trading
$1.50 -0.01 (-0.33%)
As of 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About PAVmed Stock (NASDAQ:PAVM)

Advanced

Key Stats

Today's Range
$1.45
▼
$1.75
50-Day Range
$1.34
▼
$4.52
52-Week Range
$1.17
▼
$28.44
Volume
38,984 shs
Average Volume
24,005 shs
Market Capitalization
$12.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Hold

Company Overview

PAVmed Inc. is a medical technology company that develops and commercializes medical devices and diagnostic products. Its portfolio includes technologies aimed at addressing unmet needs in areas such as cancer detection, vascular access and minimally invasive procedures.

Through its subsidiary Lucid Diagnostics, PAVmed is associated with EsoGuard, a molecular test designed to detect precancerous changes linked to esophageal cancer, and EsoCheck, a device used to collect cells from the esophagus. PAVmed has also developed PortIO, an intraosseous access device intended to provide a route for delivering fluids and medication.

Founded in 2014, PAVmed is based in the United States and focuses primarily on developing technologies for the U.S. healthcare market.

AI Generated. May Contain Errors.

PAVmed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

PAVM MarketRank™: 
2.0083709806 of 5 stars

PAVmed scored higher than 40% of companies evaluated by MarketBeat, and ranked 660th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PAVmed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

  • Upside Potential

    PAVmed has a consensus price target of $56.00, representing about 3,608.6% upside from its current price of $1.51.

  • Amount of Analyst Coverage

    PAVmed has only been the subject of 1 research reports in the past 90 days.

  • Read more about PAVmed's stock forecast and price target.
  • Earnings Growth

    Earnings for PAVmed are expected to decrease in the coming year, from ($3.80) to ($3.82) per share.

  • Percentage of Shares Shorted

    0.19% of the float of PAVmed has been sold short.
  • Short Interest Ratio / Days to Cover

    PAVmed has a short interest ratio ("days to cover") of 1.04, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PAVmed has recently increased by 0.75%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    PAVmed does not currently pay a dividend.

  • Dividend Growth

    PAVmed does not have a long track record of dividend growth.

  • News Sentiment

    PAVmed has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for PAVmed this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    3 people have added PAVmed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PAVmed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.40% of the stock of PAVmed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    19.93% of the stock of PAVmed is held by institutions.

  • Read more about PAVmed's insider trading history.
Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PAVM Stock News Headlines

PAVmed Earnings Call Highlights Lucid and Device Progress
PAVmed Inc. Q3 2026 Earnings Call Summary
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
PAVmed (PAVM) Q3 2026 Earnings Call Transcript
Transcript : PAVmed Inc., Q3 2026 Earnings Call, Nov 13, 2026
See More Headlines

PAVM Stock Analysis - Frequently Asked Questions

PAVmed's stock was trading at $7.33 on January 1st, 2026. Since then, PAVM stock has decreased by 79.4% and is now trading at $1.51.

PAVmed Inc. (NASDAQ:PAVM) announced its earnings results on Thursday, May, 14th. The company reported ($1.17) EPS for the quarter, missing the consensus estimate of ($0.69) by $0.48. The business earned $22 thousand during the quarter, compared to analysts' expectations of $74 thousand. PAVmed had a negative trailing twelve-month return on equity of 61.95% and a negative net margin of 12,406.76%.
Read the conference call transcript
.

PAVmed shares reverse split on the morning of Friday, January 2nd 2026.The 1-30 reverse split was announced on Tuesday, December 30th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, December 31st 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of PAVM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PAVmed investors own include NIO (NIO), NVIDIA (NVDA), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), Plug Power (PLUG), Micron Technology (MU) and Block (XYZ).

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:PAVM
CIK
1624326
Fax
N/A
Employees
41
Year Founded
2014

Price Target and Rating

High Price Target
$56.00
Low Price Target
$56.00
Potential Upside/Downside
+3,608.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($9.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$400 thousand
Net Margins
-12,406.76%
Pretax Margin
-14,669.64%
Return on Equity
-61.95%
Return on Assets
-17.08%

Debt

Debt-to-Equity Ratio
0.98
Current Ratio
1.19
Quick Ratio
1.19

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
172.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.42) per share
Price / Book
-0.62

Miscellaneous

Outstanding Shares
8,000,000
Free Float
6,925,000
Market Cap
$12.08 million
Optionable
No Data
Beta
0.92

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:PAVM) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners